Gary K. Schwartz

Atezolizumab for Advanced Alveolar Soft Part Sarcoma.

J. Doroshow, M. Burgess, B. V. Van Tine, 2023, The New England journal of medicine.

Sarcoma Immunotherapy: Past Approaches and Future Directions

G. Schwartz, W. Tap, R. Carvajal, 2014, Sarcoma.

High-risk features in radiation-associated breast angiosarcomas

L. Qin, C. Antonescu, S. D'Angelo, 2013, British Journal of Cancer.

Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by Plx3397 and Rapamycin as a Potential New Approach for the Treatment of Mpnsts Translational Relevance

W. Tap, E. de Stanchina, O. Surriga, 2022 .

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.

L. Qin, C. Antonescu, Helen X. Chen, 2013, The Lancet. Oncology.